ArticlePolymers2019
Super-Toughened Poly(lactic Acid) with Poly(ε-caprolactone) and Ethylene-Methyl Acrylate-Glycidyl Methacrylate by Reactive Melt Blending.
Article in Polymers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Flexible Silver/Polyaniline Schottky Diodes on a Polyethylene Based Elastomer: A Sustainable Approach for Advanced Electronics.ACS applied electronic materials · 2025Article
- Article
- Guanidine Derivatives Leverage the Antibacterial Performance of Bio-Based Polyamide PA56 Fibres.Polymers · 2024Article
- Enhanced Mechanical Properties of Polylactic Acid/Poly(Butylene Adipate-co-Terephthalate) Modified with Maleic Anhydride.Polymers · 2024Article
- Investigating the Effect of PCL Concentrations on the Characterization of PLA Polymeric Blends for Biomaterial Applications.Materials (Basel, Switzerland) · 2022Article
- Analysis of PLA Composite Filaments Reinforced with Lignin and Polymerised-Lignin-Treated NFC.Polymers · 2021Article
- Development of Toughened Flax Fiber Reinforced Composites. Modification of Poly(lactic acid)/Poly(butylene adipate-co-terephthalate) Blends by Reactive Extrusion Process.Materials (Basel, Switzerland) · 2021Article
- Toughening of Poly(l-Lactide) with Branched Polycaprolactone: Effect of Chain Length.ACS omega · 2020Article
- Article
- Structural and Thermo-Mechanical Properties of Poly(ε-caprolactone) Modified by Various Peroxide Initiators.Polymers · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, poly(lactic acid) (PLA) has attracted more and more attention as one of the most promising biobased and biodegradable polymers. However, the inherent brittleness significantly limits its wide application. Here, ternary blends of PLA, poly(ε-caprolactone) (PCL) with various amounts of ethylene-methyl acrylate-glycidyl methacrylate (EMA-GMA) terpolymer were fabricated through reactive melt blending in order to improve the toughness of PLA. The effect of different addition amounts of EMA-GMA on the mechanical properties, interfacial compatibility and phase morphology of PLA/PCL blends were studied. The reactions between the epoxy groups of EMA-GMA and carboxyl and hydroxyl end groups of PLA and PCL were investigated thorough a Fourier transform infrared (FT-IR). The miscibility and thermal behavior of the blends were studied through a dynamic mechanical analysis (DMA), differential scanning calorimetric (DSC) and X-ray diffraction (XRD). The phase morphology and impact fracture surface of the blends were also investigated through a scanning electron microscope (SEM). With the addition of 8 phr EMA-GMA, a PLA/PCL (90 wt %:10 wt %)/EMA-GMA ternary blend presenting a suitable multiple stacked phase structure with an optimum interfacial adhesion exhibited an elongation at break of 500.94% and a notched impact strength of 64.31 kJ/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.